Top Markets
#1 ADO Protocol ADO Protocol +195.93%
#2 Islamic Coin Islamic Coin +155.37%
#3 GoPlus Security GoPlus Security +59.90%
#4 Starpower Starpower +25.13%
#5 GAIB AID GAIB AID +24.67%
#6 The Black Bull The Black Bull +15.10%
#7 Casper Network Casper Network +14.54%
#8 Verus Coin Verus Coin +13.55%
#9 Status Status +12.46%
#10 o1.exchange o1.exchange +10.83%
Coin of the day
ADO Protocol ADO Protocol
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Bharat Immunologicals & Biologicals Corporation Limited Bharat Immunologicals & Biologicals Corporation Limited

Bharat Immunologicals & Biologicals Corporation Limited

BIBCL
Classement en actions #33424
Bharat Immunologicals & Biologicals Corp. Ltd. operates as a biotechnology... Bharat Immunologicals & Biologicals Corp. Ltd. operates as a biotechnology enterprise, primarily involved in the development and manufacture of pharmaceutical goods. Its offerings include vital products such as oral polio vaccines, zinc tablets, comprehensive diarrhea management kits, and ready-to-consume therapeutic foods. The firm organizes its operations into several key divisions: Oral Polio Vaccine (OPV), Zinc Tablets, BIB VIT, and BIBSANIT. Founded on March 10, 1989, the company's main office is situated in Bulandshahr, India.
Prix de l'action
$0.17580153
Capitalisation boursière
$7.59M
Changement (1 jour)
-0.13%
Changement (1 an)
-30.21%
Pays
IN
Échange Bharat Immunologicals & Biologicals Corporation Limited (BIBCL)

Catégorie

Healthcare
Ratio P/B pour Bharat Immunologicals & Biologicals Corporation Limited (BIBCL)
Ratio P/B au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Bharat Immunologicals & Biologicals Corporation Limited, le ratio cours/valeur comptable actuel (TTM) est 0. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour Bharat Immunologicals & Biologicals Corporation Limited de 2026 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
Pas assez de données pour les dates fournies.
Ratio P/B pour des entreprises similaires ou concurrentes
Entreprise Ratio P/B Différence de Ratio P/B Pays
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 3.817 -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 17.0911 -
US